Bill
Bill > HR5799
US HR5799
Medicaid DRUG Improvement Act Medicaid Drug Review, Utilization, Good Governance Improvement Act
summary
Introduced
05/15/2018
05/15/2018
In Committee
05/17/2018
05/17/2018
Crossed Over
Passed
Dead
12/31/2018
12/31/2018
Introduced Session
115th Congress
Bill Summary
Medicaid DRUG Improvement Act Medicaid Drug Review, Utilization, Good Governance Improvement Act This bill requires state Medicaid programs to establish drug-review and utilization requirements for enrollees, particularly with respect to opioid prescriptions. Drug use review programs must also identify prescribing or billing practices by providers that indicate abuse or excessive utilization.
AI Summary
This bill, the Medicaid Drug Review, Utilization, Good Governance Improvement Act or the Medicaid DRUG Improvement Act, requires state Medicaid programs to establish drug-review and utilization requirements for enrollees, particularly with respect to opioid prescriptions. It mandates that states implement certain claims review limitations, such as safety edits and automated processes to monitor opioid, benzodiazepine, and antipsychotic prescriptions. The bill also requires states to have programs to monitor the use of antipsychotic medications by children enrolled in Medicaid and to have processes to identify potential fraud or abuse of controlled substances. Additionally, the bill amends the Medicaid drug use review program to require the identification and remediation of prescribing or billing practices that indicate abuse or excessive utilization.
Committee Categories
Business and Industry
Sponsors (4)
Last Action
Placed on the Union Calendar, Calendar No. 563. (on 06/12/2018)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
Loading...